Month: <span>July 2022</span>

Home / 2022 / July
Gut bacteria potential key to IBD and colon cancer prevention
Post

Gut bacteria potential key to IBD and colon cancer prevention

by University of Queensland Credit: Pixabay/CC0 Public Domain Researchers have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel disease treatments and potentially help prevent some forms of bowel cancer. The study by University of Queensland and Mater researchers identified gut bacterial strains that suppress inappropriate gut inflammation and...

Higher cortisol levels may help predict risk of people developing depression in the future
Post

Higher cortisol levels may help predict risk of people developing depression in the future

by Trinity College Dublin Ball-and-stick model of the cortisol (hydrocortisone) molecule. Credit: Public Domain Higher levels of the stress hormone cortisol may increase the risk of developing depression, according to new research from Trinity. Researchers from The Irish Longitudinal Study on Aging (TILDA) found that higher cortisol levels in older adults, measured from hair samples collected...

Myrkl: new anti-hangover pill said to break down up to 70% of alcohol in an hour—what you need to know
Post

Myrkl: new anti-hangover pill said to break down up to 70% of alcohol in an hour—what you need to know

by Ashwin Dhanda, The Conversation Credit: Rawpixel/Shutterstock A new anti-hangover supplement has just gone on sale in the UK. It is marketed by Swedish firm Myrkl as “the pre-drinking pill that works.” The pill is said to break down up to 70% of alcohol after 60 minutes. This means that if someone drinks 50ml of 40% spirits, which...

A wearable device to assist individuals with the rare genetic condition PIEZO2-LOF
Post

A wearable device to assist individuals with the rare genetic condition PIEZO2-LOF

by Ingrid Fadelli, Medical Xpress Credit: Kodali et al. (2022) The Piezo-type mechanosensitive ion channel component 2, or PIEZO2, is a protein coding gene that has been linked to mechanically-activated (MA) cation channels, which connect mechanical forces to biological signals. The PIEZO2 encoded protein can quickly adapt MA currents in somatosensory neurons, which are responsible...

Post

New method improves diagnosis of fatty liver disease

MEDICAL UNIVERSITY OF VIENNA (Vienna, 05 July 2022) It is important to know whether patients have non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease (ALD), as this distinction plays a key role in treatment and prognosis but cannot be reliably determined by established diagnostic means. In a study led by MedUni Vienna, a new...

Nicotine-salt e-cig pods may harm immune cells more than other vapes
Post

Nicotine-salt e-cig pods may harm immune cells more than other vapes

By Rich Haridy July 03, 2022 A new study has found users of pod-based nicotine-salt e-cigarettes had markers of immune suppression not seen in users of other e-cigarette devices Depositphotos New research from the UNC School of Medicine has found users of nicotine-salt-containing pod and disposable e-cigarettes display unique markers of immune suppression not seen...

Post

CAN SCUBE3 GET LOST HAIR TO GROW AGAIN?

It may offer a therapeutic treatment for androgenetic alopecia, a common form of hair loss in both women and men. The study in Developmental Cell determined the precise mechanism by which the dermal papilla cells—specialized signal-making fibroblasts at the bottom of each hair follicle—promote new growth. Although it’s well known that dermal papilla cells play a pivotal...

Atezolizumab translates into survival benefit for bladder cancer patients with ctDNA positivity
Post

Atezolizumab translates into survival benefit for bladder cancer patients with ctDNA positivity

by European Association of Urology Credit: Unsplash/CC0 Public Domain Researchers who treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab have found that patients whose blood contained circulating tumor DNA (ctDNA), responded very well to the treatment. The study is presented today at the European Association of Urology annual congress (EAU22),...